1-13 of 13
Keywords: Sorafenib
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2023) 16 (1): 1087–1094.
Published Online: 11 October 2023
... pulmonary edema from rapid fluid remobilization into intravascular compartment. Drug-induced etiology is an important diagnostic consideration in cancer patients, particularly with use of antimetabolites, immunostimulants, and monoclonal antibodies. Sorafenib-mediated capillary leak syndrome has never been...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2022) 14 (3): 1567–1573.
Published Online: 05 November 2021
... shortly after introduction and subsequently progressed on sunitinib and nilotinib. The patient started fourth-line treatment with sorafenib with an impressive response to a point at which metastases intra-abdominally and in the liver could be resected. After surgery, sorafenib was restarted. Due...
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2020) 13 (1): 478–484.
Published Online: 30 April 2020
... with a large CHC, which was radically resected, but the 53-year-old female patient subsequently developed pulmonary metastases. Histology demonstrated low-differentiated CHC without microsatellite instability. Treatment with sorafenib was started but was stopped due to angioedema. Under subsequent gemcitabine...
Journal Articles
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2016) 9 (1): 134–137.
Published Online: 19 February 2016
.... In this case, multiple liver tumors existed in both lobes. Also this patient did not agree to receive surgical resection including liver transplantation. Chemotherapy with sorafenib at a dose of 400 mg/body twice a day was started. About 6 months later, CT findings revealed that these tumors were shrinking...
Journal Articles
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2015) 8 (1): 83–87.
Published Online: 11 February 2015
... treatment. We aim at reviewing our experience with sorafenib treatment of a patient with FLT3 mutation in refractory metastatic colorectal cancer. Methods: Treatment with sorafenib of a patient with metastatic colorectal cancer and FLT3 translocation who had previously been heavily treated. Results...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Case Rep Oncol (2011) 4 (1): 16–18.
Published Online: 15 January 2011
.... Temsirolimus Chromophobe renal cell cancer Liver metastases Sunitinib Sorafenib Case Rep Oncol 2011;4:16 18 DOI: 10.1159/000323804 Published online: January 15, 2011 © 2011 S. Karger AG, Basel ISSN 1662 6575 www.karger.com/cro This is an Open Access article licensed under the terms of the Creative...
Journal Articles
Journal Articles